前收市價 | 11.36 |
開市 | 11.32 |
買盤 | 11.20 x 800 |
賣出價 | 11.21 x 1400 |
今日波幅 | 11.02 - 11.32 |
52 週波幅 | 6.68 - 19.48 |
成交量 | |
平均成交量 | 2,170,733 |
市值 | 1.122B |
Beta 值 (5 年,每月) | 1.25 |
市盈率 (最近 12 個月) | 8.19 |
每股盈利 (最近 12 個月) | 1.37 |
業績公佈日 | 2024年7月31日 |
遠期股息及收益率 | 無 (無) |
除息日 | 2014年2月28日 |
1 年預測目標價 | 12.10 |
NEW YORK (Reuters) -Nestle's new food brand for people taking weight-loss drugs like Wegovy will note that the meals are high in protein, fiber and nutrients, but will not name the blockbuster medications, a company executive told Reuters. The world's largest food maker is keeping the names of the drugs off the packaging due to regulatory concerns, Tom Moe, Nestle USA's president of meals, said in a recent interview. Nestle will instead market its Vital Pursuit line of $5-and-under frozen meals on social media, he said.
FactSet 最新調查:賀寶芙(HLF-US)EPS預估下修,預估EPS、預估營收、目標價、歷史獲利表現、即時新聞資訊。
While I tend to prefer writing about the market in the third person, the topic of fitness and the business world around it is a personal matter to me. After all, the fitness market, unlike technology or defense, relies on us, the average person, to remain relevant. For me, staying fit through gym memberships has never quite yielded the same results as spending time outdoors, and I think the reality is the same for most of us. Unless you live in extreme weather conditions like the deserts of Ariz